These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 28733702)

  • 1. Anti-invasive effects of CXCR4 and FAK inhibitors in non-small cell lung carcinomas with mutually inactivated p53 and PTEN tumor suppressors.
    Dragoj M; Bankovic J; Sereti E; Stojanov SJ; Dimas K; Pesic M; Stankovic T
    Invest New Drugs; 2017 Dec; 35(6):718-732. PubMed ID: 28733702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting CXCR4 and FAK reverses doxorubicin resistance and suppresses invasion in non-small cell lung carcinoma.
    Dragoj M; Milosevic Z; Bankovic J; Tanic N; Pesic M; Stankovic T
    Cell Oncol (Dordr); 2017 Feb; 40(1):47-62. PubMed ID: 27822706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.
    Lu C; Shan Z; Hong J; Yang L
    Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-proliferation and anti-metastasis effect of barbaloin in non-small cell lung cancer via inactivating p38MAPK/Cdc25B/Hsp27 pathway.
    Zhang Z; Rui W; Wang ZC; Liu DX; Du L
    Oncol Rep; 2017 Aug; 38(2):1172-1180. PubMed ID: 28656293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of CXCR4 regulates epithelial mesenchymal transition of NSCLC via the Hippo-YAP signaling pathway.
    Zheng CH; Chen XM; Zhang FB; Zhao C; Tu SS
    Cell Biol Int; 2018 Sep; 42(10):1386-1394. PubMed ID: 29972256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upregulation of CXCR4 is functionally crucial for maintenance of stemness in drug-resistant non-small cell lung cancer cells.
    Jung MJ; Rho JK; Kim YM; Jung JE; Jin YB; Ko YG; Lee JS; Lee SJ; Lee JC; Park MJ
    Oncogene; 2013 Jan; 32(2):209-21. PubMed ID: 22370645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SIRT3 deacetylates and promotes degradation of P53 in PTEN-defective non-small cell lung cancer.
    Xiong Y; Wang L; Wang S; Wang M; Zhao J; Zhang Z; Li X; Jia L; Han Y
    J Cancer Res Clin Oncol; 2018 Feb; 144(2):189-198. PubMed ID: 29103158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Focal Adhesion Kinase Inhibitors in Combination with Erlotinib Demonstrate Enhanced Anti-Tumor Activity in Non-Small Cell Lung Cancer.
    Howe GA; Xiao B; Zhao H; Al-Zahrani KN; Hasim MS; Villeneuve J; Sekhon HS; Goss GD; Sabourin LA; Dimitroulakos J; Addison CL
    PLoS One; 2016; 11(3):e0150567. PubMed ID: 26962872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. G9a Promotes Invasion and Metastasis of Non-Small Cell Lung Cancer through Enhancing Focal Adhesion Kinase Activation via NF-κB Signaling Pathway.
    Sun T; Zhang K; Pangeni RP; Wu J; Li W; Du Y; Guo Y; Chaurasiya S; Arvanitis L; Raz DJ
    Mol Cancer Res; 2021 Mar; 19(3):429-440. PubMed ID: 33298547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apoptosis induced by the methanol extract of Salvia miltiorrhiza Bunge in non-small cell lung cancer through PTEN-mediated inhibition of PI3K/Akt pathway.
    Ye YT; Zhong W; Sun P; Wang D; Wang C; Hu LM; Qian JQ
    J Ethnopharmacol; 2017 Mar; 200():107-116. PubMed ID: 28088493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential expression of CXCR4 is associated with the metastatic potential of human non-small cell lung cancer cells.
    Su L; Zhang J; Xu H; Wang Y; Chu Y; Liu R; Xiong S
    Clin Cancer Res; 2005 Dec; 11(23):8273-80. PubMed ID: 16322285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting Focal Adhesion Kinase and Resistance to mTOR Inhibition in Pancreatic Neuroendocrine Tumors.
    François RA; Maeng K; Nawab A; Kaye FJ; Hochwald SN; Zajac-Kaye M
    J Natl Cancer Inst; 2015 Aug; 107(8):. PubMed ID: 25971297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 3'3-Diindolylmethane inhibits migration, invasion and metastasis of hepatocellular carcinoma by suppressing FAK signaling.
    Li WX; Chen LP; Sun MY; Li JT; Liu HZ; Zhu W
    Oncotarget; 2015 Sep; 6(27):23776-92. PubMed ID: 26068982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bu Fei Decoction attenuates the tumor associated macrophage stimulated proliferation, migration, invasion and immunosuppression of non-small cell lung cancer, partially via IL-10 and PD-L1 regulation.
    Pang L; Han S; Jiao Y; Jiang S; He X; Li P
    Int J Oncol; 2017 Jul; 51(1):25-38. PubMed ID: 28534943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The investigation of mitogen-activated protein kinase phosphatase-1 as a potential pharmacological target in non-small cell lung carcinomas, assisted by non-invasive molecular imaging.
    Tai CJ; Wu AT; Chiou JF; Jan HJ; Wei HJ; Hsu CH; Lin CT; Chiu WT; Wu CW; Lee HM; Deng WP
    BMC Cancer; 2010 Mar; 10():95. PubMed ID: 20226009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CXCR4 promotes cisplatin-resistance of non-small cell lung cancer in a CYP1B1-dependent manner.
    Xie S; Tu Z; Xiong J; Kang G; Zhao L; Hu W; Tan H; Tembo KM; Ding Q; Deng X; Huang J; Zhang Q
    Oncol Rep; 2017 Feb; 37(2):921-928. PubMed ID: 27922681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiation/paclitaxel treatment of p53-abnormal non-small cell lung cancer xenograft tumor and associated mechanism.
    Li G; Zhao J; Peng X; Liang J; Deng X; Chen Y
    Cancer Biother Radiopharm; 2012 May; 27(4):227-33. PubMed ID: 22489661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Krüppel-like factor 8 activates the transcription of C-X-C cytokine receptor type 4 to promote breast cancer cell invasion, transendothelial migration and metastasis.
    Mukherjee D; Lu H; Yu L; He C; Lahiri SK; Li T; Zhao J
    Oncotarget; 2016 Apr; 7(17):23552-68. PubMed ID: 26993780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro and in vivo therapeutic efficacy of CXCR4 antagonist BKT140 against human non-small cell lung cancer.
    Fahham D; Weiss ID; Abraham M; Beider K; Hanna W; Shlomai Z; Eizenberg O; Zamir G; Izhar U; Shapira OM; Peled A; Wald O
    J Thorac Cardiovasc Surg; 2012 Nov; 144(5):1167-1175.e1. PubMed ID: 22925564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-7 inhibits cell proliferation, migration and invasion in human non-small cell lung cancer cells by targeting FAK through ERK/MAPK signaling pathway.
    Cao Q; Mao ZD; Shi YJ; Chen Y; Sun Y; Zhang Q; Song L; Peng LP
    Oncotarget; 2016 Nov; 7(47):77468-77481. PubMed ID: 27764812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.